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Abstract 
Purpose: To evaluate the antihyperlipidemic efficacy and phytochemical constituents of Vernonia 
elaeagnifolia aqueous leaf extract. 
Method: Qualitative phytochemical analysis of V. elaeagnifolia leaves was performed. Thirty healthy 
albino rabbits were divided into six groups (n = 6). Cholesterol powder (0.5 g/kg) in 10 mL coconut oil 
(vehicle) was given orally to induce hyperlipidemia. The aqueous leaf extract of Vernonia elaeagnifolia 
was administered at 250 mg/kg and 500 mg/kg per oral. Lipid profile, hepatic enzymes and oxidative 
stress markers were evaluated. 
Results: Phytochemical screening indicated the presence of tannins, proteins, flavonoids, phenols, 
alkaloids and saponins. Oral administration of cholesterol powder significantly (p < 0.05) raised the level 
of serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c) and triglyceride (TG) along 
with significant (p < 0.05) decrease in serum concentration of high-density lipoprotein cholesterol (HDL-
c). Concentration of serum TC, LDL-c, TG and liver enzymes was significantly reduced in V. 
elaeagnifolia-treated groups. The levels of oxidative stress markers were restored to normal when the 
animals were treated with V. elaeagnifolia leaf extract; increased levels of antioxidant enzymes were 
observed. 
Conclusion: The aqueous leaf extract of V. elaeagnifolia possesses antihyperlipidemic and antioxidant 
potentials that are dose-dependent. However, further studies are required to develop the plant for 
therapeutic applications. 
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Variations in normal functions of body alter the 
homeostasis which may lead towards serious 
health problems such as hypercholesteremia [1]. 
Hyperlipidemia is a heterogeneous metabolic 
disorder. It plays an important role in the 
progression of life threatening cardiovascular 
diseases such as myocardial infarction, cardiac 
arrest and angina. The major accounting 
problems of hyperlipidemia are increase in serum 
cholesterol level and oxidative stress [2]. Plaque 
formation takes place in the blood vessels when 
excess of LDL cholesterol gets accumulated in 
the endothelial spaces. It may worsen 
hypertension and normal functioning of liver and 
kidney [3,4]. 
 
Various types of antihyperlipidemic drugs are 
being used e.g. Statins (simvastatin, atorvastatin 
etc.), fibrates, ezetimibe, nicotinic acid and fish 
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oils (omega-3 fatty acids) in order to decrease 
the serum cholesterol level [5]. Use of these 
synthetic medications may lead towards severe 
irregularities including abnormal liver function, 
hyperuricemia and dry skin [6]. Statins are 
involved in increasing hepatic transaminase level 
in the serum upon prolonged use [7]. 
 
Medicinal plants have been widely used in 
Ayurveda system of medicine. Evidences from 
literature favor the use of medicinal plants 
because they increase the immunity of body 
against various diseases [8]. V. elaeagnifolia 
(Asteraceae) is a creeper. It is mostly cultivated 
in Asia and Europe. Plants of this family have 
medicinal properties against upper respiratory 
tract infections, stomach ulceration and skin 
infections [9]. Chemical constituents found in V. 
elaeagnifolia ethanolic extract are flavonoids, 
phenolic compounds, tannins, terpenoids, 
phytosterols, alkaloids, and coumarins. 
Conventionally V. elaeagnifolia leaves are being 
used as leech repellent [10]. 
 
Current investigation was designed to investigate 
the anti-hyperlipidemic activity of aqueous extract 






30 healthy albino rabbits (aged, 1 year; body 
weight, 2.0 ± 0.2 kg) of either sex were procured 
from local market of Faisalabad, Pakistan. The 
rabbits were kept in iron cages at temperature of 
25º C and 12 h dark/12 h light cycle. The rabbits 
were on normal feed (lucern) and water ad 
libitum. Compliance with the rules was made by 
following Principles of Laboratory Animal Care 
(NIH publication No. 85-23, revised 1985) [11]. 
All the trials conducted on animals were 
approved from the Committee of Animal 
Experimentation by the use of First Affiliated 
Brooke Hospital University of Agriculture 




Cholesterol powder was purchased from Sigma 
Aldrich (Germany). Atorvastatin (Tab. Atorsan, 
10 mg; standard drug) was procured from 
Novartis Pharmaceuticals Co., (Batch no, 




The leaves of V. elaeagnifolia were obtained 
from local market of Faisalabad, Pakistan. These 
were identified from Department of Botany, 
University of Agriculture, Faisalabad. In order to 
remove dust from leaves, they were washed with 
tap water. Afterwards leaves were dried in 
shade. Dried leaves were ground in electric 
grinder to have fine powder. The grounded 




Animals were categorized into 5 groups where 
each group was containing 6 animals. Group 1 
was normal group in which animals were fed on 
routine diet only; Group 2 was hyperlipidemic 
control and received cholesterol (0.5 g/kg) in 
coconut oil (10 ml); Group 3 was positive control 
and received cholesterol powder + atorvastatin 
(0.25 mg/kg) p.o; Group 4 was treated group I 
and received cholesterol powder + V. 
elaeagnifolia aqueous extract (250 mg/kg) p.o; 
group 5 was treated group II and received 
cholesterol powder + V. elaeagnifolia aqueous 
extract (500 mg/kg) orally. 
 




Proximate composition (moisture content, dry 
matter, ether extract, total ash, crude protein and 
crude fiber) of V. elaeagnifolia leaves was 




One g of the powdered sample of V. 
elaeagnifolia leaves was digested with digestion 
mixture (nitric acid and perchloric acid) at 180 – 
200 ºC. Resulting transparent solvent was diluted 
with double distilled water up to 100 mL. This 
digested solution was used to determine 
elements through Atomic Absorption 
spectrophotometry (AAS; Hitachi Polarized 
Zeeman, Z-8200, Japan), according to the 
protocols described in AOAC (Association of 




Phytochemical screening of V. elaeagnifolia 
leaves was done according to standard protocols 
for proteins, alkaloids, tannins, fixed oils, 
saponins and flavonoids [14].  
 
Preparation of extract 
 
Dried powder of leaves was added into soxhlet 
apparatus along with petroleum ether and 
extraction was carried out. The extract was 
subjected to hot water bath for evaporation. 
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Dried residue was collected and used as 




Blood samples were collected from jugular vein 
located in the neck via venous puncture. Blood 
was centrifuged at 1000 rpm for 10 min to isolate 
serum. Serum total cholesterol (TC), triglyceride 
(TG), HDL-c, LDL-c, ALP, ALT, AST, TAC, MDA, 
TOS, Catalase and SOD were measured using 





Animals were sacrificed via decapitation on 45th 
day of experiment. Liver tissues were collected 
and fixed in neutral formalin solution. These 
tissues were processed for light microscopy 
according to reference methods for embedding, 
sectioning, mounting and staining with 
hematoxylin & eosin. Light microscope (Olympus 
optical Co., Tokyo, Japan) with 40 X objective 




Statistical analysis was done by using one way 
ANOVA tailed by Duncan’s Multiple Range test 
to determine statistical differences at 5% level of 
significance. SPSS software version 3.16 was 







Results for the proximate composition are 
summarized in Table 1. 
 
Table 1: Proximate profile of V. elaeagnifolia leaves 
 
Parameter         % 
Moisture content        9.5 
Dry matter        90.5 
Fiber content        20.8 
Fat content        5.55 
Crude protein        10.3 




Concentration of Sodium (Na), Cobalt (Co), 
Magnesium (Mg), Cadmium (Cd), Lead (Pb), 
Calcium (Ca), Manganese (Mn), Potassium (K), 
Iron (Fe)  Zinc (Zn,) Nickel (Ni), and Copper (Cu) 
present in leaves of V. elaeagnifolia are 
expressed as mg/kg ± SE and shown in Table 2. 
 
Table 2: Elemental composition of Vernonia 
elaeagnifolia leaf (mg/kg, mean ± SE) 
 












Phytochemical constituents  
 
Qualitative phytochemical analysis of V. 
elaeagnifolia evidenced the presence of 
saponins, proteins, phenols, flavonoids, tannins, 
and alkaloids as represented in Table 3. 
 
Table 3: Phytochemical profile of Vernonia 
elaeagnifolia leaf 
 










The amount of serum total cholesterol (TC), and 
triglyceride was significantly (p < 0.05) raised 
after the administration of cholesterol powder 
among all groups in comparison to the normal 
control. Serum concentration of triglyceride and 
total cholesterol in atorvastatin and V. 
elaeagnifolia treated groups showed significant 
reduction in dose dependent manner (Figure 1). 
 
Serum concentration of LDL cholesterol was 
increased while significantly (p < 0.05) 
decreased in cholesterol treated groups. When 
treated with V. elaeagnifolia then it restored the 
levels of LDL cholesterol and HDL cholesterol in 
comparison to normal control (Figure 2). 
 
Amount of hepatic enzymes; alanine 
transaminase, alkaline phosphatase and 
aspartate transaminase was elevated 
significantly (p < 0.05) in cholesterol treated 
groups, when treated with V. elaeagnifolia then 
concentration of hepatic enzymes was 
decreased near to the normal as shown in Table 
4. 
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Figure 1: Effect of V. elaeagnifolia leaf extract on (a): serum total cholesterol (mg/dL ± SE) and (b): serum 
triglycerides (mg/dL ± SE). Error bars with changing letters have significant difference (p < 0.05) whereas; V.250 




Figure 2: Effect of V. elaeagnifolia leaf extract on (a): LDL cholesterol (mg/dL ± SE) and (b): HDL cholesterol 
(mg/dL ± SE). Error bars with changing letters have significant difference (p < 0.05) whereas; V.250 (V. 
elaeagnifolia; 250 mg/kg), V.500 (V. elaeagnifolia; 500 mg/kg). 
 
Table 4: Effect of V. elaeagnifolia leaf extract on hepatic enzymes 
 
Group Aspartate transaminase  Alanine transaminase  Alkaline phosphatase  
 (U/L) (U/L) (U/L) 
CTRL 52.00±2.67 D 39.83±1.47 D 12.66±1.89 A 
CHOL 97.50±3.66 A 89.16±1.74 A 36.83±1.88 B 
ATORVA 76.83±2.96 B 57.66±2.02 B   24.66±0.98 CB 
V. 250 76.83±2.96 B 56.83±1.49 B 26.50±1.72 C 
V. 500 66.83±2.84 C 45.33±1.05 C 21.33±0.88 D 
Data is expressed as mean ± SE (n = 6); comparison is made among normal control, hyperlipidemic control and 
V. elaegnifolia treated groups. Changing alphabets in columns exhibit data is significantly different (p < 0.05) 
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Table 5: Effect of V. elaeagnifolia leaf extract on antioxidant and oxidant parameters 
 
Group TOS TAC Catalase  MDA SOD 
 (µmol/L) (mmol/L) (KU/L) (mmol/L) (Units/mg 
of protein) 
CTRL 3.66±0.05 A 0.56±0.02 A  40.10±1.04 A    8.83±0.35 D 7.97±0.46 A 
CHOL 8.08±0.24 B 0.25±0.01 D  17.93±0.64 D 51.42±0.85 A 1.08±0.05 D 
ATORVA  4.49±0.12 CB 0.40±0.01 C  35.86±1.19 B 24.77±1.18 B 5.45±0.18 C 
V. 250    4.96±0.24 C 0.36±0.01 C  30.30±1.04 C 23.31±0.81 B 5.83±0.16 C 
V. 500 4.35±0.19 D 0.45±0.01 B   38.45±0.73 AB 13.21±0.74 C 6.99±0.17 B 
Data are expressed as mean ± SE (n = 6); comparison is made among normal control, hyperlipidemic control and 
V. elaegnifolia treated groups. Changing alphabets in columns exhibit data is significantly different (p < 0.05) 
 
 
Figure 3: Histopathological features of hepatic tissue at 40 X; A: Normal control, B: Cholesterol (0.5 g/kg) treated 
group, C: atorvastatin (0.25 mg/kg) treated group, D: V. elaeagnifolia (250 mg/kg) treated group, E: V. 
elaeagnifolia (500 mg/kg) treated group 
 
Oxidative stress markers, total oxidant status 
(TOS) and malondialdehyde (MDA) levels were 
increased when treated with cholesterol while the 
amount in serum was restored when V. 
elaeagnifolia was given. Administration of 
cholesterol increased the oxidative stress and 
decreased the concentration of antioxidant 
enzymes (Catalase; SOD) and total antioxidant 
capacity. Treatment with V. elaeagnifolia 
increased the antioxidant capacity and amount of 
antioxidant enzymes as represented in Table 5. 
 
As shown in Figure 3, liver tissue from control 
rabbit showed distinctive and clear boundaries of 
hepatic cells. While lobular structure of 
hepatocytes was disrupted in hepatic tissue 
obtained from hyperlipidemic rabbit. In addition, 
necrotic and binucleate cells were present. In 
atorvastatin treated animal, hepatocytes were 
resized to normal with lesser binucleate cells. 
When treated with 250 mg/kg of V. elaeagnifolia 
then it reversed the state of liver injury towards 
normal with few hazy hepatocytes. Appearance 
of hepatocytes in V. elaeagnifolia (500 mg/kg) 
treated rabbit was just alike to hepatic cells of 
atorvastatin treated animal. Parenchyma of cells 





Current investigation was conducted to 
investigate the antihyperlipideic efficacy of V. 
elaeagnifolia aqueous leaf extract. For the 
induction of hyperlipidemia, cholesterol powder 
was administered to the animal models that 
increased the oxidative stress and serum 
cholesterol concentration. Hyperlipidemia is a 
major risk factor in the progression of 
cardiovascular diseases [15].  
 
It was observed that micro and macro nutrients 
(calcium, manganese, magnesium, potassium, 
zinc, iron, cobalt and sodium) were present in V. 
elaeagnifolia leaves whereas heavy metals (lead, 
cadmium) were absent. 
 
Previous research studies suggest that macro 
and micro nutrients have role in lowering the 
serum total cholesterol and free fatty acids. In 
another study it was observed that presence of 
calcium in sufficient amount in body enhances 
the process of fat digestion [16]. Calcium plays a 
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major role in the formation of non-esterified 
linkages fatty acids in the small intestine. 
Calcium helps in the formation of insoluble soap 
with esterified fatty acids. This complex becomes 
more water soluble and readily gets eliminated 
from body via feces [17]. In one investigation it 
was found that micronutrients (zinc, manganese 
and copper) potentiate the antioxidant activity of 
super oxide dismutase, as SOD is involved in 
neutralizing lipid peroxides [18]. 
 
In the present study phytochemical screening 
indicated the presence of major phyto-
constituents (flavonoids, proteins, alkaloids, 
tannins, saponins and tannins). It was observed 
in another research that presence of these phyto-
constituents exert hypolipdemic effect. Previous 
literature claims that intake of saponin 
supplementation enhance the excretion of bile 
salts. Cholesterol is involved in the formation of 
bile salts. Thus excretion of bile salts results in 
decreased serum cholesterol. It was reported 
that flavonoids are phenolic compounds that 
potentiate the activity of lecithin acyl transferase 
(LCAT) enzyme, which in turn enhances the 
process of fat metabolism [19].  
 
In present investigation, serum level of TC, LDL 
cholesterol and TG was elevated whereas HDL 
concentration was reduced when treated with 
cholesterol (0.5 g/kg). Serum concentration of 
TG, LDL cholesterol, TC and HDL-c was restored 
to normal level when treated with V. elaegnifolia 
aqueous leaf extract. These findings were 
supported by another research in which lemon 
juice was administered to hyperlipidemic animal 
model resulted in pronounced decrease in LDL 
cholesterol, TC and triglycerides [20].  
 
V. elaeagnifolia significantly (p < 0.05) lowered 
the amount of TOS and MDA in the serum 
whereas level of antioxidant enzyme i.e. CAT 
and SOD was increased. Similar results were 
observed in another research when grape fruit 
juice was given to hyperlipidemic mice that 
resulted in decreased oxidative stress and 
increased serum level of antioxidant enzymes 
[21].  
 
It was observed in the present study that V. 
elaeagnifolia reduced the levels of heptic 
enzymes i.e. aspartate transaminase, alkaline 
phosphatase and alanine transaminase.  These 
findings were supported by previous research 
undertaken to evaluate antihyperlipidemic effect 
of ginseng extract. Administration of ginseng 
extract restored the serum levels of hepatic 
enzymes, in addition concentration of serum 




The findings of this study indicate that 
administration of V. elaeagnifolia aqueous leaf 
extract produced anti-hyperlipidemic and 
antioxidant effects in rabbits. However, further 
investigational studies are required to elucidate 
the cellular mechanisms involved in 
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